Trial · NCT01675154
Adverse event totals48
The totals the trial posted for each group.
1 to 20 of 48
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | 1st Intervention Period:SLx-4090 Placebo/Orlistat Placebo | 0 | 2 |
| Total, all-cause mortality | 1st Intervention Period:Orlistat/Placebo | 0 | 1 |
| Total, all-cause mortality | 1st Intervention Period:Orlistat Placebo /Slx-4090 | 0 | 1 |
| Total, all-cause mortality | 1st Intervention Period:Orlistat/SLx-4090 | 0 | 1 |
| Total, all-cause mortality | 2nd Intervention Period:SLx-4090 Placebo/Orlistat Placebo | 0 | 1 |
| Total, all-cause mortality | 2nd Intervention Period:Orlistat/Placebo | 0 | 1 |
| Total, all-cause mortality | 2nd Intervention Period:Orlistat Placebo /Slx-4090 | 0 | 1 |
| Total, all-cause mortality | 2nd Intervention Period:Orlistat/SLx-4090 | 0 | 2 |
| Total, all-cause mortality | 3rd Intervention Period:SLx-4090 Placebo/Orlistat Placebo | 0 | 1 |
| Total, all-cause mortality | 3rd Intervention Period:Orlistat/Placebo | 0 | 1 |
| Total, all-cause mortality | 3rd Intervention Period:Orlistat Placebo /Slx-4090 | 0 | 1 |
| Total, all-cause mortality | 3rd Intervention Period:Orlistat/SLx-4090 | 0 | 0 |
| Total, all-cause mortality | 4th Intervention Period:SLx-4090 Placebo/Orlistat Placebo | 0 | 1 |
| Total, all-cause mortality | 4th Intervention Period:Orlistat/Placebo | 0 | 0 |
| Total, all-cause mortality | 4th Intervention Period:Orlistat Placebo /Slx-4090 | 0 | 1 |
| Total, all-cause mortality | 4th Intervention Period:Orlistat/SLx-4090 | 0 | 0 |
| Total, other adverse events | 1st Intervention Period:SLx-4090 Placebo/Orlistat Placebo | 0 | 2 |
| Total, other adverse events | 1st Intervention Period:Orlistat/Placebo | 1 | 1 |
| Total, other adverse events | 1st Intervention Period:Orlistat Placebo /Slx-4090 | 1 | 1 |
| Total, other adverse events | 1st Intervention Period:Orlistat/SLx-4090 | 1 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01675154/event-totals